Raras
Buscar doenças, sintomas, genes...
Síndrome QT longo familiar congênito
ORPHA:768CID-10 · I49.8CID-11 · BC65.0DOENÇA RARA

Uma doença genética do coração caracterizada por um eletrocardiograma (ECG) de rotina que mostra que o coração leva mais tempo do que o normal para "recarregar" entre um batimento e outro (o que chamamos de "intervalo QT" prolongado). Essa condição também apresenta um alto risco de causar arritmias (batimentos cardíacos irregulares) que podem ser muito perigosas para a vida.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença genética do coração caracterizada por um eletrocardiograma (ECG) de rotina que mostra que o coração leva mais tempo do que o normal para "recarregar" entre um batimento e outro (o que chamamos de "intervalo QT" prolongado). Essa condição também apresenta um alto risco de causar arritmias (batimentos cardíacos irregulares) que podem ser muito perigosas para a vida.

Publicações científicas
1.097 artigos
Último publicado: 2026 Apr 6
Medicamentos
5 registrados
RANOLAZINE, IVACAFTOR, LUMACAFTOR

Tem tratamento?

5 medicamentos registrados
Ver detalhes, fases e interações →
RANOLAZINEIVACAFTORLUMACAFTORPRINABERELDOFETILIDE

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +10CID-10: I49.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
30 sintomas
😀
Face
16 sintomas
🦴
Ossos e articulações
14 sintomas
🧠
Neurológico
8 sintomas
👂
Ouvidos
7 sintomas
📏
Crescimento
6 sintomas

+ 42 sintomas em outras categorias

Características mais comuns

Testa larga
Anemia ferropriva
Deficiência auditiva neurossensorial profunda
Mal-estar pós-esforço
Arritmia
Perda de consciência
141sintomas
Sem dados (141)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 141 características clínicas mais associadas, ordenadas por frequência.

Testa largaBroad forehead
Anemia ferroprivaIron deficiency anemia
Deficiência auditiva neurossensorial profundaProfound sensorineural hearing impairment
Mal-estar pós-esforçoPostexertional malaise
ArritmiaArrhythmia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.097PubMed
Últimos 10 anos200publicações
Pico202548 papers
Linha do tempo
2026Hoje · 2026🧪 1985Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

21 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

CALM1Calmodulin-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:23893133, PubMed:26969752, PubMed:27165696, PubMed:28890335, PubMed:31454269, PubMed:35568036). Among the

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium, flagellum

VIAS BIOLÓGICAS (10)
Cam-PDE 1 activationFCGR3A-mediated IL10 synthesisPKA activationSmooth Muscle ContractionCa2+ pathway
MECANISMO DE DOENÇA

Ventricular tachycardia, catecholaminergic polymorphic, 4

An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT4 inheritance is autosomal dominant.

OUTRAS DOENÇAS (4)
long QT syndrome 14catecholaminergic polymorphic ventricular tachycardia 4catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1442UniProt:P0DP23
ALG10BDol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase BCandidate gene tested inTolerante
FUNÇÃO

Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase that operates in the biosynthetic pathway of dolichol-linked oligosaccharides, the glycan precursors employed in protein asparagine (N)-glycosylation. The assembly of dolichol-linked oligosaccharides begins on the cytosolic side of the endoplasmic reticulum membrane and finishes in its lumen. The sequential addition of sugars to dolichol pyrophosphate produces dolichol-linked oligosaccharides containing fourteen sugars, includi

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
OUTRAS DOENÇAS (1)
long QT syndrome 2
HGNC:HGNC:31088UniProt:Q5I7T1
TBX5T-box transcription factor TBX5Candidate gene tested inAltamente restrito
FUNÇÃO

DNA-binding protein that regulates the transcription of several genes and is involved in heart development and limb pattern formation (PubMed:25725155, PubMed:25963046, PubMed:26917986, PubMed:27035640, PubMed:29174768, PubMed:8988164). Binds to the core DNA motif of NPPA promoter (PubMed:26926761)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (3)
YAP1- and WWTR1 (TAZ)-stimulated gene expressionPhysiological factorsCardiogenesis
MECANISMO DE DOENÇA

Holt-Oram syndrome

Developmental disorder affecting the heart and upper limbs. It is characterized by thumb anomaly and atrial septal defects.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
71.0 TPM
Pulmão
35.0 TPM
Esôfago - Muscular
20.7 TPM
Esôfago - Junção
15.3 TPM
Coração - Ventrículo esquerdo
14.7 TPM
OUTRAS DOENÇAS (2)
Holt-Oram syndromefamilial long QT syndrome
HGNC:11604UniProt:Q99593
NOS1APCarboxyl-terminal PDZ ligand of neuronal nitric oxide synthase proteinCandidate gene tested inRestrito
FUNÇÃO

Adapter protein involved in neuronal nitric-oxide (NO) synthesis regulation via its association with nNOS/NOS1. The complex formed with NOS1 and synapsins is necessary for specific NO and synapsin functions at a presynaptic level. Mediates an indirect interaction between NOS1 and RASD1 leading to enhance the ability of NOS1 to activate RASD1. Competes with DLG4 for interaction with NOS1, possibly affecting NOS1 activity by regulating the interaction between NOS1 and DLG4 (By similarity). In kidn

LOCALIZAÇÃO

Cell projection, filopodiumCell projection, podosome

MECANISMO DE DOENÇA

Nephrotic syndrome 22

A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form that progresses to end-stage renal failure. NPHS22 is an autosomal recessive, steroid-resistant form characterized by onset of progressive kidney dysfunction in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
20.8 TPM
Brain Frontal Cortex BA9
14.7 TPM
Córtex cerebral
11.6 TPM
Brain Anterior cingulate cortex BA24
9.1 TPM
OUTRAS DOENÇAS (2)
nephrotic syndrome, type 22familial long QT syndrome
HGNC:16859UniProt:O75052
TRDNTriadinCandidate gene tested inTolerante
FUNÇÃO

Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation-contraction coupling in the heart and in regulating the rate of heart beats

LOCALIZAÇÃO

Cell membraneSarcoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Ion homeostasisStimuli-sensing channels
MECANISMO DE DOENÇA

Cardiac arrhythmia syndrome, with or without skeletal muscle weakness

An autosomal recessive cardiac disorder characterized by stress-induced arrhythmias in infancy or early childhood. Patients present with recurrent syncope or cardiac arrest after physical activity or emotional stress. Sudden death may occur in early childhood. Some patients have muscle weakness.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
361.9 TPM
Coração - Átrio
55.6 TPM
Coração - Ventrículo esquerdo
40.6 TPM
Fallopian Tube
7.3 TPM
Pituitária
6.6 TPM
OUTRAS DOENÇAS (3)
catecholaminergic polymorphic ventricular tachycardia 5catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:12261UniProt:Q13061
SCN10ASodium channel protein type 10 subunit alphaCandidate gene tested inTolerante
FUNÇÃO

Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Episodic pain syndrome, familial, 2

An autosomal dominant neurologic disorder characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.5 TPM
Coração - Átrio
0.1 TPM
Aorta
0.1 TPM
Coração - Ventrículo esquerdo
0.0 TPM
Artéria coronária
0.0 TPM
OUTRAS DOENÇAS (7)
episodic pain syndrome, familial, 2paroxysmal extreme pain disorderfamilial long QT syndromeBrugada syndrome
HGNC:10582UniProt:Q9Y5Y9
KCNH2Voltage-gated inwardly rectifying potassium channel KCNH2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel (PubMed:10219239, PubMed:10753933, PubMed:10790218, PubMed:10837251, PubMed:11997281, PubMed:12063277, PubMed:18559421, PubMed:22314138, PubMed:22359612, PubMed:26363003, PubMed:27916661, PubMed:9230439, PubMed:9351446, PubMed:9765245). Channel properties are modulated by cAMP and subunit assembly (PubMed:10837251). Characterized by unusual gating kinetics by producing relatively small outward currents during mem

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationVoltage gated Potassium channels
MECANISMO DE DOENÇA

Long QT syndrome 2

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Deafness is often associated with long QT syndrome type 2.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
85.3 TPM
Cólon sigmoide
75.2 TPM
Cerebelo
71.0 TPM
Cérebro - Hemisfério cerebelar
64.7 TPM
Testículo
62.0 TPM
OUTRAS DOENÇAS (4)
short QT syndrome type 1long QT syndrome 2short QT syndromefamilial long QT syndrome
HGNC:6251UniProt:Q12809
KCNJ5G protein-activated inward rectifier potassium channel 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium. This potassium channel is control

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
MECANISMO DE DOENÇA

Long QT syndrome 13

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
62.9 TPM
Pituitária
25.4 TPM
Baço
10.2 TPM
Pâncreas
8.2 TPM
Rim - Medula
6.3 TPM
OUTRAS DOENÇAS (5)
familial hyperaldosteronism type IIIlong QT syndrome 13familial atrial fibrillationAndersen-Tawil syndrome
HGNC:6266UniProt:P48544
AKAP9A-kinase anchor protein 9Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus (PubMed:10202149, PubMed:15047863). Required for microtubule nucleation at the cis-side of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (PubMed:25657325). In complex with PDE4DIP isoform 13/MMG8/SMYLE, recruit

LOCALIZAÇÃO

Golgi apparatusCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (9)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Long QT syndrome 11

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

OUTRAS DOENÇAS (3)
long QT syndrome 11Brugada syndromefamilial long QT syndrome
HGNC:379UniProt:Q99996
KCNJ2Inward rectifier potassium channel 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:36149965, PubMed:7590287, PubMed:9490857). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:7590287, PubMed:7696590). The inward rectification is mainly due to the blockage of outward current by inter

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsClassical Kir channelsPhase 4 - resting membrane potentialSensory perception of sour taste
MECANISMO DE DOENÇA

Long QT syndrome 7

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
10.1 TPM
Brain Spinal cord cervical c-1
9.1 TPM
Sangue
6.5 TPM
Coração - Ventrículo esquerdo
5.5 TPM
Mama
5.1 TPM
OUTRAS DOENÇAS (5)
short QT syndrome type 3Andersen-Tawil syndromeatrial fibrillation, familial, 9short QT syndrome
HGNC:6263UniProt:P63252
KCNE2Potassium voltage-gated channel subfamily E member 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits (PubMed:10219239, PubMed:11034315, PubMed:11101505, PubMed:12185453, PubMed:20533308). KCNE2 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:10219239, PubMed:11034315, PubMed:11101505, PubMed:12185453, PubMed:20533308). Alters the gating of the

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Long QT syndrome 6

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Estômago
306.8 TPM
Testículo
5.9 TPM
Aorta
2.9 TPM
Nervo tibial
2.6 TPM
Artéria tibial
2.5 TPM
OUTRAS DOENÇAS (4)
long QT syndrome 6atrial fibrillation, familial, 4familial long QT syndromefamilial atrial fibrillation
HGNC:6242UniProt:Q9Y6J6
SCN5ASodium channel protein type 5 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneCytoplasm, perinuclear regionCell membrane, sarcolemma, T-tubuleCell junction

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Progressive familial heart block 1A

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
36.1 TPM
Coração - Ventrículo esquerdo
35.1 TPM
Cervix Ectocervix
5.3 TPM
Cervix Endocervix
4.1 TPM
Nervo tibial
2.9 TPM
OUTRAS DOENÇAS (16)
progressive familial heart block, type 1Aventricular fibrillation, paroxysmal familial, type 1sick sinus syndrome 1long QT syndrome 3
HGNC:10593UniProt:Q14524
CALM2Calmodulin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:26969752, PubMed:27165696). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:26969752, PubMed:27165696, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
CASP4 inflammasome assemblyEnterobacterial factors antagonize host defense
MECANISMO DE DOENÇA

Long QT syndrome 15

A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

OUTRAS DOENÇAS (3)
long QT syndrome 15catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1445UniProt:P0DP24
CACNA1CVoltage-dependent L-type calcium channel subunit alpha-1CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemmaPerikaryonPostsynaptic density membraneCell projection, dendriteCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
NCAM1 interactionsRegulation of insulin secretionAdrenaline,noradrenaline inhibits insulin secretionPhase 0 - rapid depolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Timothy syndrome

Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism.

OUTRAS DOENÇAS (10)
Timothy syndromelong QT syndrome 8Brugada syndrome 3neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
HGNC:1390UniProt:Q13936
CAV3Caveolin-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). Mediates the recruitment of CAVIN2 and CAVIN3 proteins to the caveolae (PubMed:19262564)

LOCALIZAÇÃO

Golgi apparatus membraneCell membraneMembrane, caveolaCell membrane, sarcolemma

VIAS BIOLÓGICAS (1)
Smooth Muscle Contraction
MECANISMO DE DOENÇA

HyperCKmia

Characterized by persistent elevated levels of serum creatine kinase without muscle weakness.

OUTRAS DOENÇAS (7)
rippling muscle disease 2distal myopathy, Tateyama typelong QT syndrome 9creatine phosphokinase, elevated serum
HGNC:1529UniProt:P56539
CALM3Calmodulin-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Calmodulin acts as part of a calcium signal transduction pathway by mediating the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding (PubMed:16760425, PubMed:31454269). Calcium-binding is required for the activation of calmodulin (PubMed:16760425, PubMed:31454269, PubMed:35568036). Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases, such as myosin light-chain kinases and calmodulin-dependent

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
CASP4 inflammasome assemblyEnterobacterial factors antagonize host defense
MECANISMO DE DOENÇA

Ventricular tachycardia, catecholaminergic polymorphic, 6

An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. CPVT6 inheritance is autosomal dominant.

OUTRAS DOENÇAS (3)
long QT syndrome 16catecholaminergic polymorphic ventricular tachycardiafamilial long QT syndrome
HGNC:1449UniProt:P0DP25
KCNQ1Potassium voltage-gated channel subfamily KQT member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of cardiomyocyte excitability and important in normal development and functions of myocardium, inner ear, stomach and colon (PubMed:10646604, PubMed:25441029). Associates with KCNE beta subunits that modulates current kinetics (PubMed:10646604, PubMed:11101505, PubMed:19687231, PubMed:8900283, PubMed:9108097, PubMed:9312006). Induces a voltage-dependent current by rapidly activating and slowly deactivatin

LOCALIZAÇÃO

Cell membraneCytoplasmic vesicle membraneEarly endosomeMembrane raftEndoplasmic reticulumBasolateral cell membraneApical cell membrane

VIAS BIOLÓGICAS (3)
Phase 2 - plateau phasePhase 3 - rapid repolarisationVoltage gated Potassium channels
MECANISMO DE DOENÇA

Long QT syndrome 1

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
207.0 TPM
Estômago
97.9 TPM
Tireoide
84.2 TPM
Pâncreas
31.9 TPM
Rim - Medula
24.6 TPM
OUTRAS DOENÇAS (8)
short QT syndrome type 2Jervell and Lange-Nielsen syndrome 1long QT syndrome 1atrial fibrillation, familial, 3
HGNC:6294UniProt:P51787
ANK2Ankyrin-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1

LOCALIZAÇÃO

Cytoplasm, cytoskeletonMembraneCytoplasm, myofibril, sarcomere, M lineApical cell membraneCell membranePostsynaptic cell membraneEarly endosomeRecycling endosomeLysosomeMitochondrionCytoplasm, myofibril, sarcomere, Z lineCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (2)
COPI-mediated anterograde transportInteraction between L1 and Ankyrins
MECANISMO DE DOENÇA

Long QT syndrome 4

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 4 shows many atypical features compared to classical long QT syndromes, including pronounced sinus bradycardia, polyphasic T waves and atrial fibrillation. Cardiac repolarization defects may be not as severe as in classical LQT syndromes and prolonged QT interval on EKG is not a consistent feature.

OUTRAS DOENÇAS (2)
cardiac arrhythmia, ankyrin-B-relatedfamilial long QT syndrome
HGNC:493UniProt:Q01484
SNTA1Alpha-1-syntrophinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein that binds to and probably organizes the subcellular localization of a variety of membrane proteins. May link various receptors to the actin cytoskeleton and the extracellular matrix via the dystrophin glycoprotein complex. Plays an important role in synapse formation and in the organization of UTRN and acetylcholine receptors at the neuromuscular synapse. Binds to phosphatidylinositol 4,5-bisphosphate (By similarity)

LOCALIZAÇÃO

Cell membrane, sarcolemmaCell junctionCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Long QT syndrome 12

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
182.9 TPM
Músculo esquelético
177.8 TPM
Brain Caudate basal ganglia
158.7 TPM
Artéria tibial
152.4 TPM
Brain Putamen basal ganglia
146.0 TPM
OUTRAS DOENÇAS (2)
long QT syndrome 12familial long QT syndrome
HGNC:11167UniProt:Q13424
SCN4BSodium channel regulatory subunit beta-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Long QT syndrome 10

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
118.2 TPM
Cerebelo
114.0 TPM
Brain Caudate basal ganglia
90.3 TPM
Brain Putamen basal ganglia
72.8 TPM
Brain Frontal Cortex BA9
45.2 TPM
OUTRAS DOENÇAS (3)
long QT syndrome 10familial atrial fibrillationfamilial long QT syndrome
HGNC:10592UniProt:Q8IWT1
KCNE1Potassium voltage-gated channel subfamily E member 1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE1 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:19219384, PubMed:20533308, PubMed:9230439). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:19219384). Associates with KCNQ1/KVLQT1 alpha subunit

LOCALIZAÇÃO

Cell membraneApical cell membraneMembrane raft

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Jervell and Lange-Nielsen syndrome 2

An autosomal recessive disorder characterized by congenital deafness, prolongation of the QT interval, syncopal attacks due to ventricular arrhythmias, and a high risk of sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Sangue
5.9 TPM
Baço
3.6 TPM
Pulmão
3.4 TPM
Adipose Visceral Omentum
1.0 TPM
Fígado
1.0 TPM
OUTRAS DOENÇAS (5)
Jervell and Lange-Nielsen syndrome 2long QT syndrome 5familial long QT syndromeJervell and Lange-Nielsen syndrome
HGNC:6240UniProt:P15382

Medicamentos e terapias

RANOLAZINEPhase 2

Mecanismo: Sodium channel protein type V alpha subunit blocker

IVACAFTORPhase 2

Mecanismo: Cystic fibrosis transmembrane conductance regulator positive modulator

LUMACAFTORPhase 2

Mecanismo: Cystic fibrosis transmembrane conductance regulator stabiliser

PRINABERELPhase 1

Mecanismo: Estrogen receptor beta agonist

DOFETILIDEPhase 1

Mecanismo: HERG blocker

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

334 variantes patogênicas registradas no ClinVar.

🧬 CALM1: NM_006888.6(CALM1):c.389A>T (p.Asp130Val) ()
🧬 CALM1: NM_006888.6(CALM1):c.270C>G (p.Phe90Leu) ()
🧬 CALM1: NM_006888.6(CALM1):c.*2238C>A ()
🧬 CALM1: NM_006888.6(CALM1):c.272G>A (p.Arg91Gln) ()
🧬 CALM1: NM_006888.6(CALM1):c.172G>A (p.Ala58Thr) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 979 variantes classificadas pelo ClinVar.

245
734
Patogênica (25.0%)
VUS (75.0%)
VARIANTES MAIS SIGNIFICATIVAS
VPS13B: NM_152564.5(VPS13B):c.3083-1G>C [Likely pathogenic]
ITPR3: NM_002224.4(ITPR3):c.3058+2T>C [Likely pathogenic]
UFM1: NM_016617.4(UFM1):c.2+1G>A [Likely pathogenic]
MBLAC1: NM_203397.3(MBLAC1):c.-28-1G>A [Likely pathogenic]
KCNQ1: NM_000218.3(KCNQ1):c.191del (p.Pro64fs) [Likely pathogenic]

Vias biológicas (Reactome)

59 vias biológicas associadas aos genes desta condição.

CaMK IV-mediated phosphorylation of CREB Calmodulin induced events Cam-PDE 1 activation CaM pathway Platelet degranulation Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation PKA activation DARPP-32 events Synthesis of IP3 and IP4 in the cytosol Calcineurin activates NFAT eNOS activation Transcriptional activation of mitochondrial biogenesis Inactivation, recovery and regulation of the phototransduction cascade Stimuli-sensing channels FCERI mediated Ca+2 mobilization Ca2+ pathway Reduction of cytosolic Ca++ levels Sodium/Calcium exchangers Unblocking of NMDA receptors, glutamate binding and activation CREB1 phosphorylation through the activation of Adenylate Cyclase CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde Ras activation upon Ca2+ influx through NMDA receptor Smooth Muscle Contraction Activation of Ca-permeable Kainate Receptor Uptake and function of anthrax toxins VEGFR2 mediated vascular permeability VEGFR2 mediated cell proliferation Phase 0 - rapid depolarisation Ion homeostasis Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein YAP1- and WWTR1 (TAZ)-stimulated gene expression Physiological factors Cardiogenesis Interaction between L1 and Ankyrins Voltage gated Potassium channels Phase 3 - rapid repolarisation Activation of G protein gated Potassium channels Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Phase 2 - plateau phase Anchoring of the basal body to the plasma membrane Signaling by BRAF and RAF1 fusions AURKA Activation by TPX2 Classical Kir channels Phase 4 - resting membrane potential Sensory perception of sour taste CASP4 inflammasome assembly Enterobacterial factors antagonize host defense Adrenaline,noradrenaline inhibits insulin secretion NCAM1 interactions Regulation of insulin secretion COPI-mediated anterograde transport Formation of the dystrophin-glycoprotein complex (DGC) Sensory perception of sweet, bitter, and umami (glutamate) taste

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 25
1Fase 13
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 5 medicamentos · 8 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome QT longo familiar congênito

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome QT longo familiar congênito

Centros para Síndrome QT longo familiar congênito

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

10 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
406 papers (10 anos)
#1

QTc measurement using Apple Watch electrocardiogram in congenital long QT syndrome.

European heart journal. Digital health2026 Apr

In congenital long QT syndrome (cLQTS), monitoring of the heart rate-corrected QT interval (QTc) is essential as even transient prolongation can significantly increase the risk of torsades de pointes and sudden cardiac death. Apple Watch (AW) offers a single-lead mobile electrocardiogram (mECG), but its accuracy for QTc monitoring remains uncertain. The objective is to analytically validate AW mECGs for QTc measurement in paediatric and adult cLQTS patients, assessing agreement, systematic bias, and lead-specific feasibility compared with standard 12-lead ECG. In this cross-sectional, dual-centre study, patients with cLQTS underwent consecutive 12-lead ECG, followed by mECG recordings of Leads I and II. QT intervals were measured by two blinded investigators, and accuracy was evaluated using Bland-Altman analysis. The study was deemed exempt from formal ethical approval by the Medical Ethics Committee of the Amsterdam UMC. Of 101 patients enrolled, 99 had ECGs suitable for QTc analysis; 15 (15.2%) were younger than 18 years and 62 (62.6%) were female. On 12-lead ECG, the mean QTc was 444.9 ± 30.2 ms (Lead I) and 449.0 ± 29.8 ms (Lead II), compared with 466.6 ± 28.9 ms (Lead I) and 470.0 ± 29.8 ms (Lead II) on mECG. The mean QTc difference (12-lead-AW) was -21.7 ms (95% limits of agreement: -53.1-9.7) for Lead I and -21.0 ms (-59.5-17.5) for Lead II. In patients with cLQTS, AW-derived mECGs may complement, but not replace, standard 12-lead ECGs for QTc assessment, pending further validation in longitudinal and unsupervised settings.

#2

KCNH2 Duplication Variant (c.2164_2181dup) Associated with Sudden Cardiac Death in a Family with Congenital Long QT Syndrome.

The Canadian journal of cardiology2026 Mar 18

Congenital Long QT syndrome (LQTS) is an inherited arrhythmogenic disorder characterized by prolonged QTc intervals and T-wave abnormalities on electrocardiogram (ECG). Prolonged QT intervals can lead to syncope, seizures, torsades de pointes, and sudden cardiac death. There are several genes, including KCNH2, known to be associated with congenital LQTS, and genetic variations in KCNH2 are known to cause a reduction in the delayed rectifier potassium current (IKr). Clinical genetic testing and variant reclassification were performed by Blueprint Genetics. The functional effect of the KCNH2 variant was quantified using a calibrated automated patch clamp electrophysiology assay. Here, we discuss a case in which post-mortem genetic testing of a 34-year-old woman revealed a variant of uncertain significance (VUS) (c.2164_2181dup) in KCNH2. Subsequent cascade genetic testing in her father and brother identified the same VUS, and both showed evidence of clinical LQTS. Patch clamp analysis shows c.2164_2181dup causes a severe loss-of-function phenotype and can be assigned with a strong level of functional evidence (PS3) for VUS reclassification. Together with previous reports of LQTS associated with c.2164_2181dup, the phenotypes observed in this family, and the strong level of functional evidence obtained from patch clamp analysis, c.2164_2181dup has been clinically reclassified as likely pathogenic.

#3

Fetal Long QT Syndrome: Case Series and Literature Review With Focus on Multidisciplinary Care Coordination.

Case reports in cardiology2026

Congenital long QT syndrome (LQTS) is a group of heritable conditions that are associated with cardiac repolarization abnormality characterized by QT prolongation on ECG and risk of life-threatening arrhythmias. Prenatal detection of LQTS presents many challenges for clinicians and a multidisciplinary approach is needed for optimal prenatal and postnatal management. We describe five cases of fetal diagnosis of LQTS with variable initial presentation, diagnostic strategies, and management approaches. A multidisciplinary team approach including fetal cardiologist, adult and pediatric electrophysiologists, medical physicists, neonatologists, maternal-fetal medicine specialists, fetal cardiac nurse coordinators, and genetic counselors allowed for comprehensive prenatal management and well-planned postnatal treatment to optimize neonatal and maternal outcomes.

#4

Newborn With Abnormal ECG and Family History of Sudden Cardiac Arrest.

NeoReviews2026 Mar 01

Congenital long QT syndrome (LQTS) is a cardiac channelopathy caused by mutations in cardiac ion channel genes, leading to delayed ventricular repolarization, QT interval prolongation, and risk of malignant arrhythmias and sudden cardiac death. The condition often presents during childhood or adolescence but can be identified in neonates, particularly when there is a positive family history. Early recognition is critical, as timely intervention with beta-blockers and avoidance of QT-prolonging medications can prevent life-threatening events. We report the case of a full-term neonate born via cesarean section to a mother with congenital long QT syndrome (LQT2) and a strong family history of arrhythmic events. On day 1 of life, screening electrocardiogram (ECG) revealed a markedly prolonged corrected QT (QTc) prompting neonatal intensive care unit admission for further monitoring and evaluation. Propranolol was initiated, resulting in gradual QTc improvement over the first week of life. Genetic testing confirmed LQT2, with a pathogenic KCNH2 variant identified. The infant remained clinically stable and asymptomatic throughout hospitalization. The diagnosis of LQTS relies on a combination of ECG findings, clinical history, and genetic testing. Beta-blockers are the first-line therapy, and avoiding QT-prolonging medications is critical. In neonates, early recognition and treatment are vital to prevent arrhythmias. This case highlights the importance of early neonatal ECG screening in the setting of a family history of LQTS and emphasizes the need for multidisciplinary approach to optimize diagnosis, treatment, and counseling.

#5

Ventricular Arrhythmias Associated With Long QT Syndrome Type 2 and Anomalous Right Coronary Artery.

JACC. Case reports2026 Feb 24

Patients with congenital long QT syndrome (LQTS) are at increased risk for sudden cardiac death. We present the case of a young woman with a history of syncopal episodes triggered by emotional stress and menstruation who experienced recurrent ventricular arrhythmias requiring implantable cardioverter-defibrillator shocks. She was diagnosed with LQTS type 2 and found to have an anomalous right coronary artery from the left coronary cusp with malignant features. This clinical case highlights the complex interplay between LQTS type 2, sex hormonal influences, and an anomalous right coronary artery in a young female patient with recurrent ventricular arrhythmias.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC467 artigos no totalmostrando 196

2026

Spatial and temporal dispersion of ventricular repolarization in pediatric patients with congenital long QT syndrome.

HeartRhythm case reports
2026

KCNH2 Duplication Variant (c.2164_2181dup) Associated with Sudden Cardiac Death in a Family with Congenital Long QT Syndrome.

The Canadian journal of cardiology
2026

QTc measurement using Apple Watch electrocardiogram in congenital long QT syndrome.

European heart journal. Digital health
2026

Fetal Long QT Syndrome: Case Series and Literature Review With Focus on Multidisciplinary Care Coordination.

Case reports in cardiology
2026

Newborn With Abnormal ECG and Family History of Sudden Cardiac Arrest.

NeoReviews
2026

Ventricular Arrhythmias Associated With Long QT Syndrome Type 2 and Anomalous Right Coronary Artery.

JACC. Case reports
2026

[Unexplained syncope and congenital long QT syndrome].

MMW Fortschritte der Medizin
2026

A Heart Under Stress: Anaesthetic Strategy for a Pregnant Patient With Long QT Syndrome.

Cureus
2026

An Effective Critical Care Unit Admission Policy for Patients With Diphenhydramine Overdose: A Case Report.

Cureus
2025

Long-term fate of long QT syndrome patients diagnosed in childhood and differential effects of beta-blockers.

Frontiers in cardiovascular medicine
2026

Management challenges in delirium in genetically confirmed long QT syndrome: a case report and discussion.

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater
2026

Congenital Long QT Syndrome Unmasked by COVID-19 Infection Presenting as Ventricular Tachycardia Storm.

JACC. Case reports
2026

Temporal variability of the electromechanical window in long-QT syndrome and drug-induced QT prolongation: Value for enhanced arrhythmia-risk assessment.

Heart rhythm
2026

High-throughput screening identifies a trafficking corrector for long QT syndrome-associated KCNQ1 variants.

JCI insight
2026

Perinatal Management of Andersen-Tawil Syndrome Using a Wearable Cardioverter-Defibrillator: A Case Report.

The journal of obstetrics and gynaecology research
2025

Mapping the Functional Landscape of KCNQ1 to Define Ion Channel Mechanisms and Arrhythmia Risk.

medRxiv : the preprint server for health sciences
2026

Is it safe for my patient with congenital long QT syndrome to participate in competitive sports?

Archives of disease in childhood
2025

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes.

The Journal of physiology
2026

Prevalence, spectrum, and outcomes in patients with nonpenetrant long QT syndrome.

Heart rhythm
2025

Long QT syndrome type 1: clinical and functional characterization of KCNQ1 variant c.1111G > C.

BMC cardiovascular disorders
2025

High Throughput Screening Identifies a Small Molecule Trafficking Corrector for Long-QT Syndrome Associated KCNQ1 Variants.

bioRxiv : the preprint server for biology
2025

Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretation.

bioRxiv : the preprint server for biology
2025

Approach to prolonged QT interval in paediatric and neonatal patients.

European journal of pediatrics
2025

KCNH2-L693P Causes Long QT Syndrome Type 2 Through hERG Channel Dysfunction: Functional Validation of a Variant of Uncertain Significance.

Molecular genetics &amp; genomic medicine
2025

A case of congenital long QT syndrome and medically induced menopause.

Post reproductive health
2025

Hashimoto's thyroiditis and congenital long QT syndrome: a dangerous addition causing torsades-case report.

European heart journal. Case reports
2025

Jervell and Lange-Nielsen Syndrome Manifesting as Seizure-Like Episodes in Childhood.

Cureus
2026

Knowledge gaps and educational needs in the perioperative management of genetic arrhythmia syndromes: a survey of the American Society of Anesthesiologists.

British journal of anaesthesia
2025

Cardiac Channelopathies in the Pediatric Patient: Long QT Syndrome.

Cardiac electrophysiology clinics
2025

Functional Profiling of KCNE1 Variants Informs Population Carrier Frequency of Jervell and Lange-Nielsen Syndrome Type 2.

Circulation. Genomic and precision medicine
2026

Optimizing Peri-Operative Pain Management in Children With Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia Undergoing Left Cardiac Sympathetic Denervation: A Case Series on Continuous Erector Spinae Plane Block and Serratus Plane Block.

Paediatric anaesthesia
2025

Beta-blocker prescription adherence of children and young people with long QT syndrome: a retrospective cohort study.

Cardiology in the young
2025

From Misdiagnosis to Recognition: Torsades de Pointes Masquerading as Non-sustained Ventricular Tachycardia.

Cureus
2025

QT Prolongation Following Premature Ventricular Contractions Leading to Ventricular Storms: A Case Report.

Cureus
2025

Generation of human induced pluripotent stem cell lines from a fetus with congenital long QT syndrome and her healthy parents.

Stem cell research
2025

A MATLAB Algorithm to Automatically Estimate the QT Interval and Other ECG Parameters and Validation Using a Machine Learning Approach in Congenital Long-QT Syndrome.

Journal of cardiovascular translational research
2025

Relationships of Circulating Plasma Metabolites With the QT Interval in a Large Population Cohort.

Circulation. Genomic and precision medicine
2025

The Risk of Breakthrough Cardiac Events Associated With Psychiatric Medications in Patients With Diagnosed and Clinically Treated Long QT Syndrome.

JACC. Clinical electrophysiology
2025

Exploring Exercise-induced Long QT: A Scoping Review of Reversibility Through Detraining and Distinction from Long QT Syndrome.

US cardiology
2025

QT interval prolongation from antipsychotics in schizophrenia and acute psychosis - A prospective study.

Industrial psychiatry journal
2025

Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article.

Cardiovascular drugs and therapy
2025

Congenital Long QT Syndrome Presenting as Ventricular Fibrillation and Syncope in a Drug-Naive Elderly Female Patient Without Prior Cardiac History.

Cureus
2025

Arrhythmogenic Cardiomyopathy Is a New Phenotype Associated With the CACNA1C p.Arg518Cys (R518C) Variant.

JACC. Clinical electrophysiology
2025

[Electrocardiographic prediction parameters for life-threatening arrhythmic events in congenital long QT syndrome patients].

Zhonghua xin xue guan bing za zhi
2025

Congenital Long QT Syndrome: A Focus on Risk Stratification and Management.

Reviews in cardiovascular medicine
2025

Demographics, Clinical Features and Genetics of Common Inherited Arrhythmias in Oman.

Journal of the Saudi Heart Association
2025

Induced Pluripotent Stem Cells in Congenital Long QT Syndrome: Research Progress and Clinical Applications.

Reviews in cardiovascular medicine
2025

Clinical, Electrical, and Mechanical Parameters in Potassium Channel-Mediated Congenital Long QT Syndrome.

Journal of clinical medicine
2025

The Prenatal Diagnosis and Perinatal Management of Congenital Long QT Syndrome: A Comprehensive Literature Review and Recent Updates.

Journal of cardiovascular development and disease
2025

Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long QT Syndrome: A Case Report.

Neuropsychopharmacology reports
2025

Acquired Genotype-Positive Long QT Syndrome After Pediatric Heart Transplantation.

Pediatric transplantation
2025

Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review.

Pharmacogenomics
2025

Congenital long QT syndrome caused by a KCNH2 pathogenic variant exhibiting "motor seizures": a case report and literature review.

BMC pediatrics
2025

Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S).

British journal of pharmacology
2025

Screening of 1-Month-Old Infants With Prolonged QT Interval and Its Cutoff Value.

Circulation journal : official journal of the Japanese Circulation Society
2025

Integrative analysis of KCNQ1 variants reveals molecular mechanisms of type 1 long QT syndrome pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America
2025

"Better Late Than Never"-Late-Onset Genotype-Negative Congenital Long QT Syndrome: Case Report and Review.

Clinical case reports
2025

Congenital Long QT Syndrome Type 7: Diagnostic Challenge Bridged by Genetic Testing.

Journal of cardiothoracic and vascular anesthesia
2025

Deep Neural Network Analysis of the 12-Lead Electrocardiogram Distinguishes Patients With Congenital Long QT Syndrome From Patients With Acquired QT Prolongation.

Mayo Clinic proceedings
2025

Contribution of continuous intravenous lidocaine in managing congenital long QT syndrome with 2:1 atrioventricular block.

Indian pacing and electrophysiology journal
2024

Management of patient with acute lymphocytic myocarditis and congenital long QT syndrome presenting with electrical storm and incessant Torsade de Pointes: a case report.

Journal of medical case reports
2024

Congenital Long QT Syndrome Masquerading as Epilepsy: A Case Report.

Cureus
2025

Novel risk predictor of arrhythmias for patients with potassium channel-related congenital long QT syndrome.

Heart rhythm
2024

Dofetilide unmasks long QT in a patient presenting with atrial fibrillation-induced cardiomyopathy.

HeartRhythm case reports
2024

Can wearables outscore general practitioners? Congenital long QT syndrome diagnosis initiated by a smartwatch.

HeartRhythm case reports
2024

Exploring Cardiac Sympathetic Denervation as a Treatment Approach for Recurrent Ventricular Arrhythmias: A Concise Review.

Journal of clinical &amp; experimental cardiology
2025

The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific manner.

Journal of molecular and cellular cardiology
2024

The fully activated open state of KCNQ1 controls the cardiac "fight-or-flight" response.

PNAS nexus
2025

Frequency and Genotype-Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome.

Journal of cardiovascular electrophysiology
2024

Compound mutations in a patient with congenital long QT syndrome: Clinical challenges and genetic interpretation.

Pediatrics international : official journal of the Japan Pediatric Society
2024

Torsades de Pointes electrical storm in children with KCNH2 mutations.

BMC medical genomics
2024

The Perfect Storm: Abnormal Baseline QT With Chronic Methadone Use and Serious Hypokalemia.

Journal of investigative medicine high impact case reports
2025

Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome.

Heart rhythm
2024

Peripartum management of cardiac arrhythmias: a narrative review.

International journal of obstetric anesthesia
2024

Congenital Long QT Syndrome Unmasked by Albuterol in an Adolescent with Asthma.

The Journal of emergency medicine
2024

Low foetal heart rate, a potentially ominous finding: case report.

European heart journal. Case reports
2024

Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population.

NPJ digital medicine
2024

Antisense Oligonucleotide Therapy for Calmodulinopathy.

Circulation
2024

What an anesthesiologist should know about pediatric arrhythmias.

Paediatric anaesthesia
2024

Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.

Circulation
2024

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India.

Indian heart journal
2025

Atrial Arrhythmia and Bradycardia as a Presentation of Congenital Long QT Syndrome.

Pediatric cardiology
2024

Ventricular Fibrillation Arrest Triggered by Antiemetics Revealing an Underlying Long QT Syndrome in a Young Woman.

Cureus
2024

Risk scores in congenital long QT syndrome: friend or foe?

European heart journal
2024

Rescue of expression and function of long QT syndrome-causing mutant hERG channels by enhancing channel stability in the plasma membrane.

The Journal of biological chemistry
2024

Identifying genomic variant associated with long QT syndrome type 2 in an ecuadorian mestizo individual: a case report.

Frontiers in genetics
2024

A mild phenotype associated with KCNQ1 p.V205M mediated long QT syndrome in First Nations children of Northern British Columbia: effect of additional variants and considerations for management.

Frontiers in pediatrics
2024

Congenital Long QT Syndrome in Children and Adolescents: A General Overview.

Children (Basel, Switzerland)
2024

Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study.

Archives of cardiovascular diseases
2024

Catheter Ablation for Channelopathies: When Is Less More?

Journal of clinical medicine
2024

Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.

Heliyon
2024

Prioritize Variant Reclassification in Pediatric Long QT Syndrome-Time to Revisit.

Pediatric cardiology
2024

Deep Learning-Augmented ECG Analysis for Screening and Genotype Prediction of Congenital Long QT Syndrome.

JAMA cardiology
2024

The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.

Cardiovascular research
2024

Fetal Arrhythmia Leading to a Diagnosis of Congenital Long QT Syndrome Type II.

JACC. Case reports
2024

Low Baseline Fetal Heart Rate Leads to Diagnosis of Long QT Syndrome Type 1.

JACC. Case reports
2024

Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.

Clinical research in cardiology : official journal of the German Cardiac Society
2024

Congenital Long QT Syndrome (LQTS) in Infancy: A Challenging Case.

Cureus
2024

Top stories on congenital long QT syndrome.

Heart rhythm
2024

Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.

JCO precision oncology
2024

Risk Prediction in Male Adolescents With Congenital Long QT Syndrome: Implications for Sex-Specific Risk Stratification in Potassium Channel-Mediated Long QT Syndrome.

Journal of the American Heart Association
2024

A case of short QT-interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia-mediated imbalance.

Journal of cardiovascular electrophysiology
2023

Congenital Long QT Syndrome, Coinciding With Cavitary Mycobacterium avium Lung Infection, Led to Cardiac Arrest.

JACC. Case reports
2023

Unlocking the Potential of Left Cardiac Sympathetic Denervation: A Scoping Review of a Promising Approach for Long QT Syndrome.

Cureus
2023

The 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval.

The Canadian journal of cardiology
2023

Long QT Syndrome: A Preventable Cause of Exercise-Induced Sudden Cardiac Death.

JACC. Case reports
2023

Congenital Long QT Syndrome and Cardiac Arrest in a Military Tactical Athlete.

JACC. Case reports
2023

KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences.

Clinics (Sao Paulo, Brazil)
2023

Spatiotemporal repolarization dispersion before and after exercise in patients with long QT syndrome type 1 versus controls: probing into the arrhythmia substrate.

American journal of physiology. Heart and circulatory physiology
2023

Total Intravenous Anaesthesia for Laparoscopic Cholecystectomy in a Patient With Congenital Long QT Syndrome: A Case Report.

Cureus
2023

Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).

Stem cell reviews and reports
2023

Genetic variant annotation scores in congenital long QT syndrome.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2023

Secular trends of health care resource utilization and costs between Brugada syndrome and congenital long QT syndrome: A territory-wide study.

Clinical cardiology
2023

Provocation testing in congenital long QT syndrome: A practical guide.

Heart rhythm
2023

Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.

JAMA cardiology
2023

Diagnostic Accuracy of the Standing Test in Adults Suspected for Congenital Long-QT Syndrome.

Journal of the American Heart Association
2023

Current gaps in knowledge in inherited arrhythmia syndromes.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
2023

A method for successfully implanting an implantable cardioverter-defibrillator wrapped with an expanded polytetrafluoroethylene sheet in a patient with metal allergy.

Journal of cardiology cases
2023

The diagnostic value of electrocardiogram-based machine learning in long QT syndrome: a systematic review and meta-analysis.

Frontiers in cardiovascular medicine
2023

Detection of QT interval prolongation using Apple Watch electrocardiogram in children and adolescents with congenital long QT syndrome.

International journal of cardiology. Heart &amp; vasculature
2023

A novel HECW2 variant in an infant with congenital long QT syndrome.

Human genome variation
2023

Same Gene, Different Story (a Case Report of Congenital Long QT Syndrome Subtype 8 With a Novel Mutation).

The American journal of cardiology
2023

Prediction of Kv11.1 potassium channel PAS-domain variants trafficking via machine learning.

Journal of molecular and cellular cardiology
2023

SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome.

Heart rhythm O2
2023

Anthracyclines for acute promyelocytic leukemia in a female with congenital long QT syndrome.

Pediatric blood &amp; cancer
2023

Whole-exome sequencing and electrophysiological study reveal a novel loss-of-function mutation of KCNA10 in epinephrine provoked long QT syndrome with familial history of sudden cardiac death.

Legal medicine (Tokyo, Japan)
2022

Mechanical QT and JT intervals by M-mode echocardiography: An extrapolation from the concurrent electrocardiographic tracings.

Annals of pediatric cardiology
2023

Bilateral cardiac sympathetic denervation in patients with congenital long QT syndrome.

Heart rhythm
2022

Cardiorespiratory fitness, muscle fitness, and physical activity in children with long QT syndrome: A prospective controlled study.

Frontiers in cardiovascular medicine
2023

Radiofrequency catheter ablation in congenital long QT syndrome: an anatomical approach to a supposedly primary electrical disease.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2023

SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.

Heart rhythm
2023

Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.

Expert reviews in molecular medicine
2022

Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.

The American journal of case reports
2022

Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.

Frontiers in physiology
2023

Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Biological Life-Stage and the Burden of Cardiac Events in Women With Congenital Long QT Syndrome.

Circulation. Arrhythmia and electrophysiology
2023

The diagnostic role of T wave morphology biomarkers in congenital and acquired long QT syndrome: A systematic review.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2022

Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K+ channels: Validation with hERG.

Frontiers in pharmacology
2022

Congenital long QT syndrome: The masquerader.

Indian journal of anaesthesia
2022

Case report of a patient with congenital long QT syndrome Type 2 presenting with electrical storm: do not judge a book by its cover!

European heart journal. Case reports
2022

Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies.

Circulation. Genomic and precision medicine
2022

Cerebral Seizures in an Adolescent with Jervell and Lange-Nielsen Syndrome: It May Not Be Epilepsy.

Clinics and practice
2022

Sex Differences and Utility of Treadmill Testing in Long-QT Syndrome.

Journal of the American Heart Association
2022

In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.

Cells
2022

Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers.

Channels (Austin, Tex.)
2022

Genotype-Specific ECG-Based Risk Stratification Approaches in Patients With Long-QT Syndrome.

Frontiers in cardiovascular medicine
2022

Utility of Provocative Testing in the Diagnosis and Genotyping of Congenital Long QT Syndrome: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association
2022

Congenital long QT syndrome: A challenging diagnosis by fetal echocardiography.

Annals of pediatric cardiology
2022

Workforce attachment after a congenital long QT syndrome diagnosis: a Danish nationwide study.

Open heart
2024

Precision therapy in congenital long QT syndrome.

Trends in cardiovascular medicine
2022

Resuscitated Sudden Cardiac Arrest of a Neonate with Congenital LQT Syndrome-Associated Torsades de Pointes: A Case Report and Literature Review.

Journal of cardiovascular development and disease
2021

CONGENITAL LONG QT SYNDROME: A SYSTEMATIC REVIEW.

Acta clinica Croatica
2022

Dilated Cardiomyopathy Phenotype-Associated Left Ventricular Noncompaction and Congenital Long QT Syndrome Type-2 in Infants With KCNH2 Gene Mutation: Anesthetic Considerations.

Journal of cardiothoracic and vascular anesthesia
2022

Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome.

Heart rhythm
2022

Pseudohypoparathyroidism: a diagnosis to consider once a PTH elevation is detected.

Acta bio-medica : Atenei Parmensis
2022

Congenital Long QT Syndrome.

JACC. Clinical electrophysiology
2023

Congenital Long QT Syndrome: A Review of Genetic and Pathophysiologic Etiologies, Phenotypic Subtypes, and Clinical Management.

Cardiology in review
2022

Sex hormones and repolarization dynamics during the menstrual cycle in women with congenital long QT syndrome.

Heart rhythm
2022

A deep learning approach identifies new ECG features in congenital long QT syndrome.

BMC medicine
2022

β-blocker adherence among patients with congenital long QT syndrome: a nationwide study.

European heart journal. Quality of care &amp; clinical outcomes
2022

Ten-year-old boy with congenital long QT syndrome type 2 (LQTS2) and life-threatening electrical storm: a case report of successful treatment with mexiletine.

Cardiology in the young
2022

Exercise Test for Patients with Long QT Syndrome.

Acta Cardiologica Sinica
2022

Congenital long QT syndrome presenting as unexplained bradycardia.

BMJ case reports
2022

Diagnostic accuracy of the 12-lead electrocardiogram in the first 48 hours of life for newborns of a parent with congenital long QT syndrome.

Heart rhythm
2022

Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.

Circulation
2021

Successful vaginal delivery in a parturient with long QT syndrome type 2 using double-catheter epidural analgesia: A CARE-compliant case report.

Medicine
2021

Structural Modelling of KCNQ1 and KCNH2 Double Mutant Proteins, Identified in Two Severe Long QT Syndrome Cases, Reveals New Insights into Cardiac Channelopathies.

International journal of molecular sciences
2022

Mutational spectrum of congenital long QT syndrome in Turkey; identification of 12 novel mutations across KCNQ1, KCNH2, SCN5A, KCNJ2, CACNA1C, and CALM1.

Journal of cardiovascular electrophysiology
2021

Torsades de pointes in the PACU after outpatient endoscopy: a case report.

BMC anesthesiology
2021

Calmodulinopathy in inherited arrhythmia syndromes.

Tzu chi medical journal
2021

[Cardiac arrest in a patient with long QT syndrome receiving androgen deprivation therapy].

Ugeskrift for laeger
2021

Induced Pluripotent Stem Cell-Derived Cardiomyocytes with SCN5A R1623Q Mutation Associated with Severe Long QT Syndrome in Fetuses and Neonates Recapitulates Pathophysiological Phenotypes.

Biology
2021

Anesthesia for a Child with Congenital Long QT Syndrome, a Case Report and Literature Review.

Anesthesia, essays and researches
2022

Severity of congenital long QT syndrome disease manifestation and risk of depression, anxiety, and mortality: a nationwide study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2021

Peculiar Aspects of Patients with Inherited Arrhythmias during the COVID-19 Pandemic.

Arquivos brasileiros de cardiologia
2021

Congenital Long QT Syndrome Type 2 with Symptomatic 2:1 Atrioventricular Block and Ventricular Arrhythmia in a Preterm Baby Who Presented with Fetal Ventricular Tachycardia and Hydrops.

Korean circulation journal
2021

Publisher Correction: Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics.

Scientific reports
2021

Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.

Stem cell research
2021

Pueraria mirifica, an estrogenic tropical herb, unveiled the severity of Type 1 LQTS caused by KCNQ1-T587M.

Journal of arrhythmia
2021

Aborted Cardiac Arrest in LQT2 Related to Novel KCNH2 (hERG) Variant Identified in One Lithuanian Family.

Medicina (Kaunas, Lithuania)
2022

Use of oral contraceptives in women with congenital long QT syndrome.

Heart rhythm
2021

Long QT-Syndrome With Torsades de Pointes Managed Considering Financial Constraints Faced by the Patient.

Cureus
2021

Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6-lead mobile ECG device and a standard 12-lead ECG.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2021

Differential diagnosis between LQT1 and LQT2 by QT/RR relationships using 24-hour Holter monitoring: A multicenter cross-sectional study.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2021

Risk Prediction in Women With Congenital Long QT Syndrome.

Journal of the American Heart Association
2021

Management of Congenital Long-QT Syndrome: Commentary From the Experts.

Circulation. Arrhythmia and electrophysiology
2021

A rare cause of platypnea-orthodeoxia syndrome in a young female due to persistent left superior vena cava.

Pacing and clinical electrophysiology : PACE
2021

Congenital long QT syndrome: a clinician's guide.

Internal medicine journal
2021

Functional evaluation of human ion channel variants using automated electrophysiology.

Methods in enzymology
2021

Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics.

Scientific reports
2021

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.

Stem cell research
2022

Diagnosis, management and therapeutic strategies for congenital long QT syndrome.

Heart (British Cardiac Society)
2021

Management of Long QT Syndrome in Women Before, During, and After Pregnancy.

US cardiology
2021

Dose response to nadolol in congenital long QT syndrome.

Heart rhythm
2021

Notice of Retraction. Shimizu et al. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients. JAMA Cardiol. 2019;4(3):246-254.

JAMA cardiology
2021

Clinical and genetic characteristics and course of congenital long QT syndrome in children: A nine-year single-center experience.

Anatolian journal of cardiology
Ver todos os 467 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome QT longo familiar congênito.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome QT longo familiar congênito

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. QTc measurement using Apple Watch electrocardiogram in congenital long QT syndrome.
    European heart journal. Digital health· 2026· PMID 41853634mais citado
  2. KCNH2 Duplication Variant (c.2164_2181dup) Associated with Sudden Cardiac Death in a Family with Congenital Long QT Syndrome.
    The Canadian journal of cardiology· 2026· PMID 41864421mais citado
  3. Fetal Long QT Syndrome: Case Series and Literature Review With Focus on Multidisciplinary Care Coordination.
    Case reports in cardiology· 2026· PMID 41822366mais citado
  4. Newborn With Abnormal ECG and Family History of Sudden Cardiac Arrest.
    NeoReviews· 2026· PMID 41763575mais citado
  5. Ventricular Arrhythmias Associated With Long QT Syndrome Type 2 and Anomalous Right Coronary Artery.
    JACC. Case reports· 2026· PMID 41733526mais citado
  6. Late diagnosis of Jervell and Lange-Nielsen syndrome in two sisters with homozygous KCNQ1 mutation.
    Cardiol Young· 2026· PMID 41940510recente
  7. Beyond ion channel dysfunction: Integration of the transcriptome and proteome from patient-specific re-engineered cardiac cells, and population-level QT genome-wide association study reveals broad cellular dysfunction.
    Heart Rhythm· 2026· PMID 41936938recente
  8. Mobile ECG for QTc assessment in cLQTS: A step toward remote monitoring.
    J Electrocardiol· 2026· PMID 41921373recente
  9. Spatial and temporal dispersion of ventricular repolarization in pediatric patients with congenital long QT syndrome.
    HeartRhythm Case Rep· 2026· PMID 41869065recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:768(Orphanet)
  2. MONDO:0019171(MONDO)
  3. GARD:16547(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q653924(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome QT longo familiar congênito
Compêndio · Raras BR

Síndrome QT longo familiar congênito

ORPHA:768 · MONDO:0019171
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive
CID-10
I49.8 · Outras arritmias cardíacas especificadas
CID-11
Medicamentos
5 registrados
Início
Adolescent, Adult, Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0023976
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades